REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Reckitt Benckiser (Singapore) Pte Ltd (Singapore)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Reckitt Benckiser (Singapore) Pte Ltd Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: manufacture of other biological products and preparations for human use (mfe & sale of household & pharmaceutical products)

Headquarters
12 Marina Boulevard, #19-01 Marina Bay Financial Centre, Singapore
Singapore; Singapore; Postal Code: 018982

Contact Details: Purchase the Reckitt Benckiser (Singapore) Pte Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Reckitt Benckiser (Singapore) Pte Ltd report to view the information.
Financial Auditors:
Purchase the Reckitt Benckiser (Singapore) Pte Ltd report to view the information.
Incorporation Date:
December 01, 1977
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Reckitt Benckiser (Singapore) Pte Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
15.92%▲
Total operating revenue
15.92%▲
Net Profit (Loss) for the Period
226.81%▲
Total assets
19.86%▲
Total equity
34.08%▲
Net Profit Margin
24.48%▲
Return on Equity (ROE)
48%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo